Homoeopathy Tablets for Lifestyle Ailments from Schwabe India

A specialized homoeopathic tablet range for lifestyle ailments from Schwabe.

New Delhi, New Delhi, November 20, 2006 /India PRwire/ -- Schwabe, the world leader in homoeopathic solutions and a leading household name in homoeopathy in India, has introduced 1X tablets, a specialized homoeopathic tablet range for lifestyle ailments. The tablets are specifically formulated ensuring that all the active ingredients of the mother tinctures remain intact in the tablet form. The drugs are so named as ‘1X tablets’, because 1X denotes its power / potency.

The range includes Bacopa monnieri 1X which is recommended for students who are under stress due to their under performance, Glycyrrhiza glabra 1X is used as an anti-inflammatory and as expectorant in respiratory complaints and is used for irritating cough and Hypericum perforatum 1X tablets are useful in nerve injuries.

Lifestyle drugs have become the fastest growing segment for the Indian pharmaceutical companies as people have become more conscious about the quality of life they lead. Schwabe India is offering these lifestyle medicines in the tablet form which have various advantages over mother tincture as this range has the convenience of tablet as well as the benefits of mother tincture. The 1X tablet range is well equipped with clinically proven homoeopathic ingredients and are prepared from plants like Brahmi, Neem and Mulethi.

These tablets can be used alone or as supplement to other medicines. Priced at Rs. 85/- and some at Rs. 175/- these tablets come in 20 gm packs and are available across India at all homoeopathic drug stores and chemist shops.

Notes to Editor

About Schwabe India

The Company is a part of the Schwabe Group, which is the oldest and the most respected homoeopathic manufacturer in the world. The parent company, Dr. Willmar Schwabe, is the leader in the production of quality natural medicines. The company was founded by Dr. Willmar Schwabe who pioneered the introduction of scientific methods and high quality standards in the manufacture of homoeopathic medicines.

With the establishment of the state of the art facility at Noida, Schwabe India brings a 140-year-old tradition of excellence in the production of homoeopathic medicines. The Noida plant, the one and only of its kind in the country, deploys the best technological know-how in the world today. The company imparts high-grade training to its employees, in the original German homoeopathic formulations, while respecting the local legal framework. The company pays a lot of stress on maintenance of cleanliness to maintain the best quality of the medicine. The quality assurance laboratory checks quality of raw materials, packaging materials and finished products.

For more information on the company you may log on to www.schwabeindia.com

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


Positive Interactive recent press release(s)


Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems In India

Company's third-generation drug-eluting stents now available in rapidly growing market

Norwegian Minister of Environment visits pilot project for solar power generation in rural India

The Norwegian Minister of Environment and International Development, Mr Erik Solheim, visited today a Community Solar Power Plant in Rampura village outside Jhansi, UP. The pilot project has been developed and executed by Scatec Solar, a leading Norwegian systems integrator of solar, photovoltaic technology.

XIENCE™ V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years

Long-term data presented for the first time today from the SPIRIT III trial, Abbott's U.S. pivotal trial studying the XIENCE™ V Everolimus Eluting Coronary Stent System, demonstrated that XIENCE V continues to deliver clinically superior benefits for patients compared to the TAXUS® paclitaxel-eluting coronary stent system. In this trial of more than 1,000 patients, XIEN...

Now in India, First time ever - safe & effective, natural, clinically proven 'BEAUTY SOLUTIONS FROM WITHIN' from Mega Lifesciences, Australia

Mega Lifesciences, a leading healthcare company, today announced its much awaited launch in India , oral consumption Skin care products - GLOW and PYNOCARE. Glow and Pynocare are the first ever oral consumption supplements in India for 'Beauty from within', addressing the skin problems faced by most Indian women concerning skin fatigue (premature ageing, dullness, rough & ...

Stryker, the world leader in Orthopaedic products, organizes a two-day course on the Exeter Total Hip Replacement System - A Live Transmission of the Surgery from Sir Ganga Ram Hospital

The two-day course on the Exeter Total Hip Replacement by Stryker, a global leader in Orthopaedic products and services, commenced here today at the India Habitat Centre. This is the second 'Exeter Course' organized in India. 120 doctors from across the country gathered to share knowledge, experiences and clinical judgements on the Exeter systems. A live Total Hip Replacem...